Drug Combination Improves Outlook for Some Patients with Chronic Lymphocytic Leukemia

| January 7, 2018 | 0 Comments
Drug Combination Improves Outlook for Some Patients with Chronic Lymphocytic Leukemia

Interim results from an ongoing clinical trial show that patients with relapsed or refractory chronic lymphocytic leukemia treated with rituximab plus venetoclax have longer progression-free survival compared with patients treated with chemotherapy.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply